Search

everythinglearnresearchcommunity

for

Search:↓

Microglia, the brain's immune cells, may contribute to Polycystic Ovary Syndrome (PCOS) by altering the female brain's structure and function, with kisspeptin neurons and GABA neurotransmitters also playing a role.

Hair loss in men may be caused by inflammation triggered by hormones, and treatments reducing inflammation could potentially promote hair growth.

Local estrogen synthesis in skin may improve wound healing.

Perilla seed extract may help prevent hair loss better than some standard treatments.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

Ginsenoside CK, found in Panax ginseng, can prevent hair loss by controlling certain growth pathways and promoting hair follicle development.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Human sebaceous glands contain enzymes that affect androgen production and may influence sebum production and acne.

Some synthesized compounds were more effective than Finasteride in reducing prostate cancer cell growth and androgen levels.

Common latent viruses might contribute to male-pattern baldness by disrupting cell processes that normally suppress hair loss-related proteins.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

CXXC5 is a protein that prevents hair growth and could be a target for hair loss treatment.

Testosterone may slow down wound healing and increase inflammation.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The conclusion is that hair loss in women is caused by a mix of hormonal, environmental, and genetic factors, and treatments should target these various causes.

Stem cells preservation in AGA could be a potential therapy, but more cases needed.

Dermal Papilla cells are a promising tool for evaluating hair growth treatments.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

Low DHEA-S levels might be linked to alopecia areata and could be a potential treatment target.

Androgen receptors found in monkey scalps, similar to humans, affect hair growth.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

A new gene, JMJD1C, may affect testosterone levels in men.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.